TFA
RMD icon

Transamerica Financial Advisors’s ResMed RMD Stock Holding History

Transamerica Financial Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.4K Buy
153
+135
+750% +$33.6K ﹤0.01% 703
2025
Q4 		$4.34K Buy
18
+5
+38% +$1.28K ﹤0.01% 991
2025
Q3 		$3.29K Buy
+13
New +$3.55K ﹤0.01% 949
2023
Q4 		– Sell
-46
Closed -$7K – 651
2023
Q3 		$7K Hold
46
– – ﹤0.01% 344
2023
Q2 		$11K Hold
46
– – ﹤0.01% 309
2023
Q1 		$11K Buy
+46
New +$9.98K ﹤0.01% 318
2013
Q4 		– Sell
-8,462
Closed -$447K – 633
2013
Q3 		$447K Sell
8,462
-7,190
-46% -$349K 0.06% 149
2013
Q2 		$707K Buy
+15,652
New +$743K 0.12% 94

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Transamerica Financial Advisors's RMD Position: Q1 2026 in Review

Transamerica Financial Advisors increased its ResMed (RMD) stake by 750% in Q1 2026, buying an estimated $33.6K and bringing the position to 153 shares worth $34.4K. The position accounts for ﹤0.01% of the portfolio, ranked #703.

Transamerica Financial Advisors first reported a position in RMD in Q2 2013 and has held it in 8 quarters since. The position peaked at $707K in Q2 2013. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Transamerica Financial Advisors held 153 shares of ResMed worth $34.4K as of Q1 2026.
  • Transamerica Financial Advisors bought 135 ResMed shares in Q1 2026, an estimated $33.6K.
  • ResMed made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q1 2026, its #703 holding.
  • Transamerica Financial Advisors first reported a position in ResMed in Q2 2013 and has held it in 8 quarters since.
  • Transamerica Financial Advisors's ResMed position peaked at $707K in Q2 2013.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Transamerica Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.